October 2024 Recap

See how different types of managers fared in October, including a strong month for Samsara BioCapital

At Old Well Labs (OWL), we’re trusted by leading endowments, foundations, and other allocators to sift through billions of data points to help them find, monitor, and connect with fund managers globally.

Our platform delivers timely insights on the positions, performance, team changes, and business trends of more than 11,000 fund managers worldwide. OWL also gathers public data about thousands of allocators, providing insights into the positions and performance of thousands of endowments, foundations, pensions, and other LPs. Every week, we curate detailed highlights from OWL for our customers. Subscribe to Allocator Insights for bite-sized highlights and trends from our data.

If you’re an allocator and would like to see the OWL platform, please reach out and schedule a demo.

At OWL, we track publicly disclosed equity positions of leading fund managers across more than 60 countries. OWL users can track daily performance estimates, risk and return metrics, exposure changes, and more for thousands of managers on our platform.

We also have “OWL Groups” – curated lists of over 500 managers frequently found in leading allocators’ portfolios. These lists are categorized by geography, sector, and style, enabling our users to monitor groups of managers and their underlying disclosed holdings directly on the OWL platform.

The table below shows how the publicly disclosed equity holdings of these groups performed during October. Growth, Financials, and Tech-focused managers’ positions outperformed in October, while international managers underperformed, with Japan, Europe, and Brazil-focused funds having a tougher month.

Biotech Bet Pays Off for Samsara

One of the top performing managers this month, according to OWL estimates, was Samsara BioCapital. Founded in 2017 by Srini Akkaraju, Samsara invests in public and private biotech companies with a hands-on approach, often taking board seats at portfolio companies. Prior to founding Samsara, Akkaraju was a general partner at Sofinnova Ventures from 2013-2016. According to public disclosures, Samsara counts Carnegie Corp and the Schmidt Family Foundation as notable LPs. OWL users can see a more detailed LP list for Samsara and thousands of other managers on our platform.

Samsara’s October performance was driven by a large investment that soared over 300% after the company released positive trial results. OWL users can see full details for this holding and thousands of other positions of leading managers on our platform. If you’d like to learn more about this data, reach out!

Invest for Charlotte – November 13th

We are helping organize 2024’s Invest for Charlotte Conference, a networking and idea-sharing event that raises money for local charities. We have great speakers from leading endowments, hedge funds, and private equity firms, and a portion of the proceeds this year will go to relief efforts in the North Carolina mountains after the devastation of Hurricane Helene. Tickets will be on sale here until November 11th.

Other News & Events

About Old Well Labs

OWL is an intelligence platform built for allocators, by allocators. Leading endowments, foundations, and family offices use the system to find, monitor, and connect with thousands of fund managers globally. OWL's analytics engine has collected over one billion data points from 65 countries. We make it easy for allocators to find and track information about the managers they care about – not just positions but also performance analytics, people data, business information, and details about the manager investments of other allocators.

Disclaimers

Returns represent the return on invested capital of publicly disclosed long positions, as calculated by OWL. Actual returns may vary based on a number of factors, including (but not limited to) undisclosed positions, short exposure, non-equity holdings, cash holdings, and lagged disclosure of positions.

This newsletter and the material on the Old Well Labs platform are for informational purposes only and should not be considered investment advice or a recommendation of any particular security, manager, or strategy. Old Well Labs shall not be liable for any investment gain or loss that may occur from the use of this material. No part of this material may be reproduced in any form or used in any publication without express written permission from Old Well Labs.